Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04129125 · ClinicalTrials.gov registry record · NA
The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
A NA study, sponsored by Imperative Care.
- Completed
- Registry status
- NA
- Development phase
- 328
- Enrollment target
NCT04129125 is a NA study that has completed, run by Imperative Care. The registered enrollment target is 328 participants.
The verdict
NCT04129125, a NA study, has completed, sponsored by Imperative Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 328 participants
- Enrollment target
Study Summary
The trial is designed to assess the safety and efficacy of using the Zoom Reperfusion System in subjects diagnosed with acute ischemic stroke and undergoing a thrombectomy procedure within 8 hours of last known well.
Interventions
- DEVICE Zoom Reperfusion System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2024-05-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04129125
The ClinicalTrials.gov registry entry for NCT04129125 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 328 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Imperative Care, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zoom Reperfusion System is the first listed.
NCT04129125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04129125 about?
NCT04129125 is a clinical study titled "The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System". The trial is designed to assess the safety and efficacy of using the Zoom Reperfusion System in subjects diagnosed with acute ischemic stroke and undergoing a thrombectomy procedure within 8 hours of last known well.
What is the current status of trial NCT04129125?
This trial is currently completed. It is a NA study. The enrollment target is 328 participants. The study started on 2021-10-01. Estimated completion is 2024-05-28.
What interventions are being tested in trial NCT04129125?
The interventions under investigation include: Zoom Reperfusion System (DEVICE).
Who is sponsoring clinical trial NCT04129125?
This trial is sponsored by Imperative Care, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.